Search
for
Sort by
Research 31–60 of 1000+
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- The Challenging Consultation: Management of Melanoma
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Therapeutic modulation of KIT ligand in melanocytic disorders with implications for mast cell diseases
- Stem Cells and their Niches
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- 53420 Temporal Trends in Sun Protective Behaviors in Hispanic and Non-Hispanic White Individuals in the United States
- AMPK Phosphorylates ZDHHC13 to Increase MC1R Activity and Suppress Melanomagenesis
- Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes
- Heme Oxygenase and the Skin in Health and Disease
- INTERFERONS IN DERMATOLOGY
- Ottawa, Ontario, Canada, February 13–16, 2013
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- Tebentafusp-tebn (Kimmtra®)
- Editors' Picks
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Primary Care of Adult Women
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Abstracts from the 4th Annual Student Medical Summit
- Pioneers in Dermatology and Venereology: an interview with Professor Francisco Miguel Camacho Martinez
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Classic versus non‐classic: A survival Kit for life in the skin
- Sun-protection behaviors of melanoma survivors
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- Scalp melanoma: Distinctive high risk clinical and histological features
- A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Association between nodular melanoma depth and area-based socioeconomic status, healthcare access, and preventive services use in the United States
- Desmoplastic melanoma presenting as primary alopecia neoplastica: a report of two cases